No Cover Image

Journal article 753 views 324 downloads

Selenium nanoparticles modulate histone methylation via lysine methyltransferase activity and S-adenosylhomocysteine depletion

BENOIT TOUBHANS, Nour Alkafri, Marcos Quintela Vazquez, David James, Caroline Bissardon, Salvatore Gazze, Franziska Knodel, Olivier Proux, Alexandra T. Gourlan, Philipp Rathert, Sylvain Bohic, Deya Gonzalez Orcid Logo, Lewis Francis Orcid Logo, Laurent Charlet, Steve Conlan Orcid Logo

Redox Biology, Volume: 61, Start page: 102641

Swansea University Authors: BENOIT TOUBHANS, Marcos Quintela Vazquez, David James, Salvatore Gazze, Deya Gonzalez Orcid Logo, Lewis Francis Orcid Logo, Steve Conlan Orcid Logo

  • 62755_VoR.pdf

    PDF | Version of Record

    © 2023 The Authors. This is an open access article under the CC BY license

    Download (8.51MB)

Check full text

DOI (Published version): 10.1016/j.redox.2023.102641

Abstract

At physiological levels, the trace element selenium plays a key role in redox reactions through the incorporation of selenocysteine in antioxidant enzymes. Selenium has also been evaluated as a potential anti-cancer agent, where selenium nanoparticles have proven effective, and are well tolerated in...

Full description

Published in: Redox Biology
ISSN: 2213-2317
Published: Elsevier BV 2023
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa62755
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract: At physiological levels, the trace element selenium plays a key role in redox reactions through the incorporation of selenocysteine in antioxidant enzymes. Selenium has also been evaluated as a potential anti-cancer agent, where selenium nanoparticles have proven effective, and are well tolerated in vivo at doses that are toxic as soluble Se. The use of such nanoparticles, coated with either serum albumin or the naturally occurring alkaline polysaccharide chitosan, also serves to enhance biocompatibility and bioavailability. Here we demonstrate a novel role for selenium in regulating histone methylation in ovarian cancer cell models treated with inorganic selenium nanoparticles coated with serum albumin or chitosan. As well as inducing thioredoxin reductase expression, ROS activity and cancer cell cytotoxicity, coated nanoparticles caused significant increases in histone methylation. Specifically, selenium nanoparticles triggered an increase in the methylation of histone 3 at lysines K9 and K27, histone marks involved in both the activation and repression of gene expression, thus suggesting a fundamental role for selenium in these epigenetic processes. This direct function was confirmed using chemical inhibitors of the histone lysine methyltransferases EZH2 (H3K27) and G9a/EHMT2 (H3K9), both of which blocked the effect of selenium on histone methylation. This novel role for selenium supports a distinct function in histone methylation that occurs due to a decrease in S-adenosylhomocysteine, an endogenous inhibitor of lysine methyltransferases, the metabolic product of methyl-group transfer from S-adenosylmethionine in the one-carbon metabolism pathway. These observations provide important new insights into the action of selenium nanoparticles. It is now important to consider both the classic antioxidant and novel histone methylation effects of this key redox element in its development in cancer therapy and other applications.
College: Faculty of Medicine, Health and Life Sciences
Funders: Benoit Toubhans received a scholarship co-funded by the Université Grenoble Alpes and Swansea University. Nour Al Kafri received a postgraduate development fellowship from the Council for At-Risk Academics (CARA). We recognise CEMHTI (Orleans, France, ANR-13-BS080012-01) and Labex OSUG@2020 (Grenoble, France, ANR-10- LABX-0056), FAME-UHD (EquipEx (EcoX, ANR-10- EQPX-27-01)) for beamtime. We thank Drs L. Sauzéat, S. Bouchet and Pr. L.H. Winkel, ETH Zürich, for ICPMS and speciation analysis. The electron microscope image was supported by the Rhône-Alpes Region, FRM, FEDER, CNRS, CEA, the University Grenoble Alpes, EMBL, GIS-IBISA, the Grenoble Instruct-ERIC Centre (ISBG: UMS 3518 CNRS-CEA-UGA-EMBL) with support from FRISBI (ANR-10-INSB-05-02) and GRAL (ANR-10-LABX-49-01) within the Grenoble Partnership for Structural Biology (PSB) platform (D. Fenel, C. Moriscot, B. Gallet and G. Schoen (PSB, ISBG, UMS 3518)). Part of this work was performed on the AccelerateAI facility, part-funded by the European Regional Development Fund through the Welsh Government via Ser Cymru.
Start Page: 102641

Similar Items